The Pharmacy

Insights on the Pharmaceutical Advertising Category

We’ve received many questions about the pharma advertising category from key industry players at agencies, media publishers, conferences, trade publications and other critical pharma constituents and stakeholders. 

This guide compiles the most commonly asked questions and places them into a one-stop-shop destination, built from the latest data and research.

You’ll Find the Answers to These Questions:

1. What is the ‘patient-driven’ case for pharma TV advertising?
2. Why is pharma TV advertising especially critical for engaging minority groups?
3. How much does the Pharma category invest in advertising?
4. What has been the effect of the FDA’s crackdown on ‘deceptive’ pharma communications?
5. How have the lengths of ad units across multiscreen TV recently evolved?
6. How does pharma investment in Spanish-language TV compare to the total market?
7. What is multiscreen TV’s impact on patient discovery, education and sales for pharma?

Why Download?

Learn more about TV advertising’s largest category, why patients benefit from the ads and how its regulation is shaping the category.

Here's a Sneak Peek: